Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-19

FDA Approved: SODIUM NITRITE — Supplemental Application (Hope Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for sodium nitrite submitted by Hope Pharmaceuticals. The approval updates the NDA for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sodium nitrite (sodium nitrite)

Snippet

SUPPL AP for SODIUM NITRITE (SODIUM NITRITE)